| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
23,250 |
20,893 |
$1.06M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,065 |
10,009 |
$818K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,322 |
7,310 |
$450K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
11,910 |
11,021 |
$394K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,876 |
12,526 |
$369K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,410 |
5,011 |
$118K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,284 |
2,189 |
$92K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,564 |
5,190 |
$85K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,112 |
5,989 |
$40K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,254 |
2,093 |
$33K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,038 |
1,890 |
$24K |
| 87428 |
|
298 |
295 |
$19K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
962 |
875 |
$11K |
| 81002 |
|
3,570 |
3,444 |
$7K |
| 87807 |
|
426 |
418 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
340 |
333 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
200 |
198 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
52 |
52 |
$3K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
229 |
201 |
$2K |
| 81025 |
|
480 |
475 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
49 |
49 |
$965.34 |
| 87400 |
|
61 |
61 |
$726.37 |
| 69209 |
|
37 |
37 |
$387.83 |
| 99051 |
|
2,791 |
2,642 |
$375.70 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
41 |
40 |
$367.54 |
| 90714 |
|
13 |
13 |
$363.29 |
| 93000 |
|
12 |
12 |
$318.61 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
14 |
$254.69 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
13 |
12 |
$249.00 |
| 94760 |
|
124 |
123 |
$242.49 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
26 |
25 |
$233.46 |
| 99072 |
|
2,363 |
2,079 |
$166.31 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$146.77 |
| 81003 |
|
73 |
72 |
$128.84 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
16 |
$114.40 |
| 87088 |
|
16 |
16 |
$97.28 |
| 82947 |
|
27 |
27 |
$79.42 |
| 85018 |
|
42 |
41 |
$76.16 |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
26 |
25 |
$57.90 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
262 |
257 |
$52.78 |